Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Details about COVID-19, monkeypox, and the flu vaccine

Neurological Evaluations for Dementia

Neurological Evaluations

Doctors will perform a neurological examination, looking at balance, sensory function, reflexes, and other functions, to identify signs of conditions—for example, movement disorders or stroke—that may affect the patient's diagnosis or are treatable with drugs.

Condition Spotlight

Inside Dementia: Stanford Hospital Offers Families Unique Support

When Our Memory Fails: Recognizing Real Loss Read Story

Dr. Longo on Dementia Play Video | 3:17

Your Health: Alzheimer's Disease & Dementia Watch Video

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Closed Trials

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) Alzheimer's Disease, Dementia

Raloxifene for Women With Alzheimer's Disease Alzheimer's Disease, Dementia

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Alzheimer's Disease, Dementia

The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients Alzheimer's Disease, Dementia